ASCO 2024: New ‘Armoured’ CAR produces significant responses in patients whose cancers don’t respond to current CAR T cell therapies
While CAR T cell therapy has revolutionised treatment for many blood cancers, including non-Hodgkin lymphoma (NHL), many…